Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9404-9412

  Günthard, Huldrych F ^a,e   Frost, Simon D W ^b   Leigh Brown, Andrew J ^b   Ignacio, Caroline C ^a   Kee, Kristin ^a   Perelson, Alan S ^c   Spina, Celsa A ^a,d   Havlir, Diane V ^a   Hezareh, Marjan ^a   Looney, David J ^a,d   Richman, Douglas D ^a,d   Wong, Joseph K ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; VIRUS ENVELOPE PROTEIN; ZIDOVUDINE;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC DISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS LATENCY; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0242629783     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9404-9412.1999     Document Type: Article

References (54)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Balfe, P., P. Simmonds, C. A. Ludlam, J. O. Bishop, and A. J. Leigh-Brown. 1990. Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J. Virol. 64:6221-6233.
3. Cavert, W., D. W. Notermans, K. Staskus, S. Wietgrefe, M. Zupancic, K. Gebhard, K. Henry, Z. Q. Zhang, R. Mills, H. McDade, J. Goudsmit, S. A. Danner, and A. T. Haase. 1997. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276:960-964.
4. Chun, T. W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. M. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV latent reservoir during highly active artiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
5. De Jong, J.-J., J. Goudsmit, W. Keulen, B. Klaver, W. Krone, M. Tersmette, and A. de Ronde. 1992. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:757-765.
6. Delassus, S., R. Cheynier, and S. Wain-Hobson. 1991. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J. Virol. 65:225-231.
7. Delwart, E. L., P. Heng, H. W. Sheppard, D. Wolpert, A. U. Neumann, B. Korber, and J. I. Mullins. 1997. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J. Virol. 71: 7498-7508.
8. Felsenstein, J. 1993. Phylogenetic inference package (Phylip) 3.5. University of Washington, Seattle.
9. Felsenstein, J. Personal communication.
10. Finzi, D., M. Hermankova, T. Pierson, L. Carruth, C. Buck, R. Chaisson, T. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. Richman, and R. Siliciano. 1997. Identification of a reservoir for HIV in patients on highly active antiretroviral therapy. Science 278:1295-1300.
11. Finzi, D., J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. C. Quinn, R. E. Chaisson, E. Rosenberg, B. Walker, S, Gange, J. Gallant, and R. F. Siliciano. 1999. Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517.
12. Fouchier, R. A. M., M. Groenink, N. A. Kootstra, M. Tersmette, H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:3183-3187.
13. Frost, S. D. W., et al. Unpublished data.
14. Furtado, M. R., D. S. Callaway, J. P. Phair, K. Kunstman, J. L. Stanton, C. A. Macken, A. S. Perelson, and S. M. Wolinsky. 1999. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340:1614-1622.
15. Gulick, R., J. W. Mellors, D. Havlir, J. Eron, C. Gonzalez, D. McMahon, L. Jonas, A. Meibohm, D. Holder, W. A. Schleif, J. H. Condra, E. Emini, R. Isaacs, J. Chodakewitz, and D. Richman. 1998. Simultaneous vs. sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100 week follow-up. JAMA 280:35-41.
16. Gulick, R. M., J. W. Mellors, D. Havlir, J. J. Eron, C. Gonzalez, D. McMahon, D. D. Richman, F. T. Valentine, P. Deutsch, A. Meibohm, D. Holder, W. A. Schleif, J. H. Condra, E. A. Emini, and J. A. Chodakewitz. 1997. Treatment with a combination of indinavir, zidovudine and lamivudine in HIV-infected adults with prior antiretroviral use. N. Engl. J. Med. 337:734-739.
17. Günthard, H. F., J. K. Wong, C. C. Ignacio, J. C. Guatelli, N. L. Riggs, D. Havlir, and D. D. Richman. 1998. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J. Virol. 72:2422-2428.
18. Hahn, B. H., G. M. Shaw, M. E. Taylor, R. R. Redfield, P. D. Markham, S. Z. Salahuddin, F. Wong-Staal, R. C. Gallo, E. S. Parks, and W. P. Parks. 1986. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 232:1548-1553.
19. Hillis, D., J. Huelsenbeck, and C. Cunningham. 1994. Application and accuracy of molecular phylogenies. Science 264:671-675.
20. Hudson, R. R. 1990. Gene genealogies and the coalescent process, p. 1-44. In D. Futuyma and J. Antonovics (ed.), Oxford surveys in evolutionary biology. Oxford University Press, Oxford, United Kingdom.
21. Kingman, J. F. C. 1982. On the genealogy of large populations, p. 27-43. In J. Gani and E. J. Hannan (ed.), Applied probability trust. Sheffield, England.
22. Korber, B. T., E. E. Allen, A. D. Farmer, and G. Myers. 1995. Heterogeneity of HIV-1 and HIV-2. AIDS 9(Suppl. A):S5-S18.
23. Korber, B. T. M., K. J. Kunstman, B. K. Patterson, M. Furtado, M. M. McEvilly, R. Levy, and S. M. Wolinsky. 1994. Genetic differences between blood-and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68:7467-7481.
24. Korber, B. T. M., K. MacInnes, R. F. Smith, and G. Myers. 1994. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J. Virol. 68:6730-6744.
25. Kuiken, C., G. Zwart, E. Baan, R. Coutinho, J. van den Hoek, and J. Goudsmit. 1993. Increasing antigenic and genetic diversity of the V3 variable domain of the HIV-1 envelope protein in the course of the AIDS epidemic. Proc. Natl. Acad. Sci. USA 90:9061-9065.
26. Kusumi, K., B. Conway, S. Cunningham, A. Berson, C. Evans, A. K. N. Iversen, D. Colvin, M. V. Gallo, S. Coutre, E. G. Shpaer, D. V. Faulkner, A. deRonde, S. Volkman, C. Williams, M. S. Hirsch, and J. I. Mullins. 1992. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 66:875-885.
27. Learn, G. H., B. T. Korber, B. Foley, B. Hahn, S. M. Wolinsky, and J. I. Mullins. 1996. Maintaining the integrity of the HIV sequence databases. J. Virol. 70:5720-5730.
28. Leitner, T., D. Escanilla, C. Franzen, M. Uhlen, and J. Albert. 1996. Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc. Natl. Acad. Sci. USA 93:10864-10869.
29. Leitner, T., S. Kumar, and J. Albert. 1997. Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with known transmission history. J. Virol. 71:4761-4770.
30. Lukashov, V. V., C. Kuiken, D. Vlahov, R. Coutinho, and J. Goudsmit. 1996. Evidence for HIV-1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. AIDS Res. Hum. Retroviruses 12:1179-1183.
31. Michael, N. L., G. Chang, P. K. Ehrenberg, M. T. Vahey, and R. R. Redfield. 1993. HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences. J. AIDS 6:1073-1085.
32. Nei, M., and L. Jin. 1989. Variances of the average numbers of nucleotide substitutions within and between populations. Mol. Biol. Evol. 6:290-300.
33. Olsen, G. J., H. Matsuda, R. Hagstrom, and R. Overbeek. 1994. FastDNAML 1.0. University of Illinois, Urbana, and Argonne National Laboratory, Argonne, Ill.
34. Page, R. D. M. 1996. Treeview: and application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358.
35. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 387:188-191.
36. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifetime, and viral generation time. Science 271:1582-1586.
37. Power, C., J. C. McArthur, R. T. Johnson, D. E. Griffin, J. D. Glass, S. Ferryman, and B. Chesebro. 1994. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol. 68:4643-4649.
38. Richman, D. D., and S. A. Bozzette. 1994. The impact of syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169:968-974.
39. Rodrigo, A. 1998. Coalescent approaches to HIV population genetics, p. 54. In Proceedings of the 5th Annual HIV Dynamics and Evolution Conference.
40. Saag, M. S., B. H. Hahn, J. Gibbons, Y. Li, E. S. Parks, W. P. Parks, and G. M. Shaw. 1988. Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 334:440-444.
41. Shankarappa, R., P. Gupla, G. Learn, A. Rodrigo, C. R. Rinaldo, Jr., M. C. Gorry, J. I. Mullins, P. L. Nara, and G. D. Ehrlich. 1998. Evolution of HIV-1 envelope sequences in infected individuals with differing disease progression profiles. Virology 241:251-259.
42. Simmonds, P., P. Balfe, C. A. Ludlam, J. O. Bishop, and A. J. Leigh-Brown. 1990. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J. Virol. 64:5840-5850.
43. Simmonds, P., L. Q. Zhang, F. McOmish, P. Balfe, C. A. Ludlam, and A. J. Leigh-Brown. 1991. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J. Virol. 65:6266-6276.
44. Speck, R. F., K. Wehrlj, E. J. Platt, R E. Alchison, I. F. Charo, D. Kabat, B. Chesebro, and M. A. Goldsmith. 1997. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids in the envelope V3 loop. J. Virol. 71:7136-7139.
45. Tajima, F. 1983. Evolutionary relationship of DNA sequences in finite populations. Genetics 105:437-460.
46. van't Wout, A., L. Ran, C. Kuiken, N. Kootstra, S. Pals, and H. Schuitemaker. 1998. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J. Virol. 72:488-496.
47. Wainberg, M. A., W. C. Drosopoulous, H. Salomon, M. Hsu, G. Borkow, M. Parniak, Z. Gu, Q. Song, J. Manne, and S. Islam. 1996. Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science 271:1282-1285.
48. Weverling, G. J., J. M. A. Lange, S. Jurriaans, J. M. Prins, V. Lukashov, D. W. Notermans, M. Roos, H. Schuitemaker, R. M. W. Hoetelmans, S. V. Danner, J. Goudsmit, and F. de Wolf. 1998. Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. AIDS 12:F117-F122.
49. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kuntsman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, et al. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
50. Wong, J. K., H. F. Gunthard, D. V. Havlir, Z. Q. Zhang, A. T. Haase, C. C. Ignacio, S. Kwok, E. A. Emini, and D. O. Richman. 1997. Reduction of HIV-1 in blood and lymph nodes following potent anti-retroviral therapy and the virologic correlates of treatment failure. Proc. Natl. Acad. Sci. USA 94:12574-12579.
51. Wong, J. K., M. Hezareh, H. F. Gunthard, D. Havlir, C. C. Ignacio, C. Spina, and D. D. Richman. 1997. Recovery of replication competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
52. Wong, J. K., C. C. Ignacio, F. Torriani, D. Havlir, N. J. S. Fitch, and D. D. Richman. 1997. In vivo compartmentalization of HIV: evidence from the examination of pol sequences from autopsy tissues. J. Virol. 70:2059-2071.
53. Zhang, H., G. Dornadula, M. Beumont, L. Livornese, Jr., B. Van Uitert, K. Henning, and R. J. Pomerantz. 1998. Human Immunodeficiency Virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med. 339:1803-1809.
54. Zhang, L., B. Ramratnam, K. Tenner-Racz, Y. He, M. Vesanen, S. Lewin, A. Talal, P. Racz, A. S. Perelson, B. T. Korber, M. Markowitz, and D. D. Ho. 1999. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 340:1605-1613.